HRS/EHRA expert consensus statement recommended that DCM patients with significant cardiac conduction disorder and/or a family history of premature unexpected SCD should undergo comprehensive or targeted (LMNA and SCN5A) genetic testing (31). The gene discussed is SCN5A; the disease is heart conduction disease.